Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide

per Camacho, Ira Espuny, Serneels, Lutgarde, Spittaels, Kurt, Merchiers, Pascal, Dominguez, Diana, De Strooper, Bart
Publicat a J Neurosci (2004)

Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model

per Tanghe, An, Termont, Annelies, Merchiers, Pascal, Schilling, Stephan, Demuth, Hans-Ulrich, Scrocchi, Louise, Van Leuven, Fred, Griffioen, Gerard, Van Dooren, Tom
Publicat 2010

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH

per Emmerson, Chris D., van der Vlist, Els J., Braam, Myrthe R., Vanlandschoot, Peter, Merchiers, Pascal, de Haard, Hans J. W., Verrips, C. Theo, van Bergen en Henegouwen, Paul M. P., Dolk, Edward
Publicat 2011

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

per Maussang, David, Mujić-Delić, Azra, Descamps, Francis J., Stortelers, Catelijne, Vanlandschoot, Peter, Stigter-van Walsum, Marijke, Vischer, Henry F., van Roy, Maarten, Vosjan, Maria, Gonzalez-Pajuelo, Maria, van Dongen, Guus A. M. S., Merchiers, Pascal, van Rompaey, Philippe, Smit, Martine J.
Publicat 2013

Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

per Van Damme, Helena, Dombrecht, Bruno, Kiss, Máté, Roose, Heleen, Allen, Elizabeth, Van Overmeire, Eva, Kancheva, Daliya, Martens, Liesbet, Murgaski, Aleksandar, Bardet, Pauline Madeleine Rachel, Blancke, Gillian, Jans, Maude, Bolli, Evangelia, Martins, Maria Solange, Elkrim, Yvon, Dooley, James, Boon, Louis, Schwarze, Julia Katharina, Tacke, Frank, Movahedi, Kiavash, Vandamme, Niels, Neyns, Bart, Ocak, Sebahat, Scheyltjens, Isabelle, Vereecke, Lars, Nana, Frank Aboubakar, Merchiers, Pascal, Laoui, Damya, Van Ginderachter, Jo Agnes
Publicat a J Immunother Cancer (2021)

CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity

per Solomon, Isabelle, Amann, Maria, Goubier, Anne, Vargas, Frederick Arce, Zervas, Dimitrios, Qing, Chen, Henry, Jake Y., Ghorani, Ehsan, Akarca, Ayse U, Marafioti, Teresa, Śledzińska, Anna, Sunderland, Mariana Werner, Demane, Dafne Franz, Clancy, Joanne Ruth, Georgiou, Andrew, Salimu, Josephine, Merchiers, Pascal, Brown, Mark Adrian, Flury, Reto, Eckmann, Jan, Murgia, Claudio, Sam, Johannes, Jacobsen, Bjoern, Marrer-Berger, Estelle, Boetsch, Christophe, Belli, Sara, Leibrock, Lea, Benz, Joerg, Koll, Hans, Sutmuller, Roger, Peggs, Karl S., Quezada, Sergio A.
Publicat a Nat Cancer (2020)